COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13034201

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Agents useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed.is hydrogen or alkyl having one, two, three, four or five carbon atoms; A is phenyl, unsubstituted or substituted by 1 or 2 groups selected from: halo, hydroxy, alkyl having 1 or 2 carbon atoms, perfluoromethyl, alkoxy having 1 or 2 carbon atoms, and perfluoromethoxy; or cycloalkyl having from 3 to 6 ring carbon atoms wherein the cycloalkyl is unsubstituted or one or two ring carbons are independently mono-substituted by methyl or ethyl; or a 5 or 6 membered heteroaromatic ring having 1 or 2 ring heteroatoms selected from N, S and O and the heteroaromatic ring is covalently bound to the remainder of the compound of formula I by a ring carbon. Alternatively, the agent can be a pharmaceutically acceptable salt of the compound of Formula I.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
WELLSTAT THERAPEUTICS CORPORATIONGAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Sharma, Shalini Gaithersburg, US 65 678
Von, Borstel Reid W Potomac, US 110 1215

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation